CANOQ — Cano Health Balance Sheet
0.000.00%
- $1.30m
- -$112.75m
- $3.14bn
- 40
- 54
- 14
- 29
Annual balance sheet for Cano Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 29.2 | 33.8 | 163 | 27.3 | 93.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 49.3 | 67.4 | 133 | 234 | 75.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 82.9 | 111 | 317 | 341 | 183 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 19.2 | 38.1 | 217 | 309 | 133 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 326 | 614 | 2,144 | 1,929 | 1,014 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 86.2 | 67.2 | 161 | 208 | 1,415 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 228 | 565 | 1,825 | 1,676 | 1,362 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 98.1 | 49.6 | 319 | 253 | -348 |
| Total Liabilities & Shareholders' Equity | 326 | 614 | 2,144 | 1,929 | 1,014 |
| Total Common Shares Outstanding |